Clinical studies recruiting near New Brunswick

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valve
NA · Robert Wood Johnson University Hospital · Edwards Lifesciences · NCT05172973 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Rutgers Cancer Institute of New Jersey · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Rutgers Cancer Institute of New Jersey-Robert Wood Johnson U · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Saint Peter's University Hospital · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Rutgers Cancer Institute of New Jersey · NRG Oncology · NCT05624996 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Saint Peter's University Hospital · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Rutgers Cancer Institute of New Jersey-Robert Wood Johnson U · National Cancer Institute (NCI) · NCT05691478 Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With P
Phase 2 · Rutgers Cancer Institute of New Jersey · Greg Durm, MD · NCT04317534 Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · Rutgers Cancer Institute of New Jersey /ID# 266833 · AbbVie · NCT06896916 Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally A
Phase 1/Phase 2 · Rutgers Cancer Institute of New Jersey · National Cancer Institute (NCI) · NCT04172532 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Saint Peter's University Hospital · Eli Lilly and Company · NCT07415044 Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
Phase 2 · Rutgers Cancer Institute of New Jersey · National Cancer Institute (NCI) · NCT04981509 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · Rutgers Cancer Institute of New Jersey · PrECOG, LLC. · NCT06538038 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Agendia · NCT03053193 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Rutgers Cancer Institute of New Jersey · Regeneron Pharmaceuticals · NCT06091865 A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-
Phase 1 · Rutgers Cancer Institute of New Jersey · Regeneron Pharmaceuticals · NCT05685173 A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Phase 1 · Rutgers Cancer Institute of New Jersey ( Site 0052) · Merck Sharp & Dohme LLC · NCT07247110 Non-Invasive Preeclampsia Screening and Biobank
Phase N/A · Rutgers Robert Wood Johnson Medical School · Sequenom, Inc. · NCT06643741 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Saint Peter's University Hospital · Children's Oncology Group · NCT04322318 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Rutgers Cancer Institute of New Jersey · NRG Oncology · NCT05946213 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Boehringer Ingelheim · NCT06531824 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Boehringer Ingelheim · NCT07220083 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Rutgers Cancer Institute of New Jersey · NRG Oncology · NCT05174169 Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · University of British Columbia · NCT04634240 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Rutgers Biomedical and Health Sciences · Kura Oncology, Inc. · NCT07007312 A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Phase 3 · Rutgers - Robert Wood Johnson Medical School · Takeda · NCT05582993 Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
Phase 2 · Rutgers Cancer Institute of New Jersey · Rutgers, The State University of New Jersey · NCT05366829 Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Phase 1 · Rutgers Cancer Institute of New Jersey · Bristol-Myers Squibb · NCT05245500 A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening
NA · New Brunswick Health Sciences Technology High School · Rutgers, The State University of New Jersey · NCT07008781 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Cancer Institute Of New Jersey · Janssen Research & Development, LLC · NCT06319820

Look up another city

Look up another condition